These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11365183)

  • 21. HIV/AIDS: Latin America & Caribbean. Peru: universal access: more goal than reality.
    Cohen J
    Science; 2006 Jul; 313(5786):489. PubMed ID: 16873658
    [No Abstract]   [Full Text] [Related]  

  • 22. New guidelines increase access to HIV/AIDS medication.
    AORN J; 2002 Sep; 76(3):448. PubMed ID: 12382663
    [No Abstract]   [Full Text] [Related]  

  • 23. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the acquired immunodeficiency syndrome on resource availability in critical care medicine in the coming decade.
    Greenbaum DM
    New Horiz; 1994 Aug; 2(3):312-20. PubMed ID: 8087589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
    Abramowitz S; Greene D
    AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is it ethical to study what ought not to happen?
    Rennie S
    Dev World Bioeth; 2006 May; 6(2):71-7. PubMed ID: 16594969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Medical ethics and economics in the era of insufficient resources].
    Bin Nun G; Afek A
    Harefuah; 2009 Mar; 148(3):144-8, 212. PubMed ID: 19485269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing efficiency and costs of scaling up HIV treatment.
    Cleary SM; McIntyre D; Boulle AM
    AIDS; 2008 Jul; 22 Suppl 1():S35-42. PubMed ID: 18664951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More people face treatment rationing as AIDS funding is cut.
    Roehr B
    BMJ; 2010 Apr; 340():c2284. PubMed ID: 20421263
    [No Abstract]   [Full Text] [Related]  

  • 31. [Economic burden and clinical course of HIV infection and AIDS today: how the variation of natural history, available treatments, and strictly related costs play a role in needs of health care].
    Manfredi R; Calza L; Gramegna A; Bocchi F; Fiacchi P; Corsini D; Chiodo F
    Recenti Prog Med; 2001 Nov; 92(11):648-54. PubMed ID: 11765655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reorienting health and social services.
    Sabatier R
    AIDS STD Health Promot Exch; 1995; (4):1-3. PubMed ID: 12346914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attitudes towards priority-setting and rationing in healthcare -- an exploratory survey of Swedish medical students.
    Omar F; Tinghög G; Tinghög P; Carlsson P
    Scand J Public Health; 2009 Mar; 37(2):122-30. PubMed ID: 19141543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV.
    Corzillius M; Mühlberger N; Sroczynski G; Jaeger H; Wasem J; Siebert U
    Antivir Ther; 2004 Feb; 9(1):27-36. PubMed ID: 15040534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral drug development: the challenge of cost and access.
    Dunne M
    AIDS; 2007 Jul; 21 Suppl 4():S73-9. PubMed ID: 17620756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV/AIDS. The great funding surge.
    Cohen J
    Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinician front lines need more resources. More patients, more problems; less time/money.
    AIDS Alert; 2008 Sep; 23(9):99-100. PubMed ID: 18939302
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.